Update information

Update information

March 2021: We produced a statement clarifying our recommendations on unlicensed cannabis-based medicinal products for severe treatment-resistant epilepsy, which should be read alongside the recommendations.

Minor changes since publication

October 2021: We added a link to NICE's guideline on babies, children and young people's experience of healthcare in recommendation 1.5.6 and to NICE's guideline on shared decision making in recommendation 1.5.11.

ISBN: 978-1-4731-3578-9

  • National Institute for Health and Care Excellence (NICE)